Weinberg Uri - Jan 5, 2023 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Science Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Uri Weinberg
Stock symbol
NVCR
Transactions as of
Jan 5, 2023
Transactions value $
-$854,216
Form type
4
Date filed
1/9/2023, 05:24 PM
Previous filing
Jul 7, 2022
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale -$285K -2.38K -4.81% $120.00 47.1K Jan 5, 2023 Direct F1
transaction NVCR Ordinary Shares Options Exercise $91.5K +1.95K +4.13% $47.04 49.1K Jan 5, 2023 Direct F1
transaction NVCR Ordinary Shares Sale -$234K -1.95K -3.97% $120.00 47.1K Jan 5, 2023 Direct F1
transaction NVCR Ordinary Shares Sale -$283K -2.62K -5.56% $108.00 44.5K Jan 5, 2023 Direct F1
transaction NVCR Ordinary Shares Sale -$144K -1.2K -2.7% $120.00 43.3K Jan 5, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Options Exercise $0 -1.95K -50% $0.00 1.95K Jan 5, 2023 Ordinary Shares 1.95K $47.04 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.
F2 Fully vested as of the date hereof.